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Abstract: Transplantation of kidneys from donors over the age of 60 yr 
is controversial. However, as the demand for cadaveric kidneys far exceeds 
the supply, exploration of the usefulness of kidneys outside the currently 
accepted donor pool is necessary. Between January 1987 and July 1989, 
31 (5.5%) of the 558 cadaveric renal transplants performed at the Univer-
sity of Pittsburgh utilized organs from donors older than 60 yr. Median 
recipient age was 41 yr (range 24-71 yr); 4 recipients were diabetic and 6 
had panel-reactive antibody levels greater than 20% at the time of 
transplant. All recipients were treated with cyclosporine, prednisone and 
azathioprine. The I-yr allograft survival was 65% which was less than but 
not statistically different from the graft survival of 800;(, in a retrospective 
selected control group who received grafts from younger donors aged 11 
to 50 yr. However, the I-yr graft survival of older donor kidneys with 
cold ischemia time greater than 48 hours was 38%, which was significant-
ly poorer than the 78% I-yr graft survival seen with cold ischemia times 
less than 48 h (p=O.04 Breslow). The mean serum creatinine was signifi-
cantly higher in the older donor kidneys at I, 3, and 12 months post-
transplant than in the control kidneys even when kidneys with greater than 
48 h of cold ischemia time were excluded. In summary, transplantation 
of cadaver kidneys from donors older than 60 yr results in acceptable graft 
survival rates. These kidneys are more susceptible to cold ischemic injury 
and function with a higher serum creatinine than kidneys from younger 
donors. Expansion of the donor pool by the use of older donor kidneys 
in selected recipients could have an impact on alleviating the chronic 
national cadaver kidney shortage. 
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Intraductlon 
In 1989 more than 100000 patients with end-stage 
renal disease were on dialysis. More than 16000 of 
these were awaiting renal transplantation, yet only 
8886 were transplanted (1). Expansion of the donor 
pool could be achieved by using kidneys from older 
donors. However, these kidneys may yield inferior 
results (2). We report a retrospective study of our 
experience over a 2-1/ 2-yr period with donors 
older than 60 yr in an attempt to evaluate their 
potential utility. 
Material and methods 
Between 1 January 1987 and 31 July 1989, 558 
renal transplants were perfonned at the University 
of Pittsburgh. Thirty-one (6%) of the kidneys were 
recovered from donors older than 60 yr. The me-
dian donor age was 62 yr (range 60 to 67 yr). There 
were 21 (68%) female and 10 (33%) male donors. 
The cause of death was intracranial bleeding in 21 
donors (68%), trauma in 8 (26%) and cardiac arrest 
in 2 (6%). The median cold ischemia time (CIT) 
was 42 h (range 20 to 60 h). The median donor 
serum creatinine was 1.1 (0.6 to 1.9 mg%). Twenty-
four (77%) of the recipients were male and 7 EO9l!~F 
were female. Median recipient age was 41 yr (range 
24 to 71), 4 patients (l30;() were diabetic and 6 
patients (19<Yo) had a panel-reactive antibody 
(PRA) level greater than 20% at the time of trans-
plantation. All patients received cycJosporine, aza-
thioprine and prednisone for immunosuppression. 
Rejection episodes were treated with high-dose 
steroids and 8 patients received OKT3 for steroid-
resistant rejections. 
Follow-up period ranged from 9 to 41 months 
(median 19 months). A retrospective recipient con-
trol group matched for PRA, incidence of diabetes, 
date of transplant, and immunosuppressive proto-
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Fig, 1. Survival of renal allografts from donors > 60 yr com-
pared to those from donors aged 18 to 50 yr. 
col who received kidneys from donors aged 18-50 
yr (Group 2) was compared to recipients of kidneys 
from donors older than 60 yr (Group 1). Table I 
illustrates the demographics of these two patient 
groups. Actuarial survival and statistical analysis 
were performed using BMDP software. 
Results 
Patient survival 
Overall l-yr patient survival in recipients of older 
( > 60 yr) donor kidneys was 87%. Two of the 4 
deaths were due to sepsis, I following cecal perfor-
ation and the other following allograft nephrec-
tomy for accelerated rejection. A 3rd patient died 
of a myocardial infarction 2 wk post-transplant. 
The 4th patient died of massive lower G. I. bleeding 
due to granulomatous enterocolitis, 6 months post-
transplant. 
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Fig. 3. Regression analysis of the int1uence of CIT on the SCR 
at 12 months in recipients of older and younger kidneys. 
Allograft survival 
The l-yr allograft survival in recipients of kidneys 
from donors older than 60 yr ~as 65°/l). This was 
not statistically different from the 80% survival 
seen in recipients of kidneys from younger donors 
(Fig. l). Allograft survival in kidneys from older 
donors with a CIT greater than 48 h (n = 8) was 
significantly decreased compared to that with CIT 
less than 48 h (76% versus 38%), p=O,04 (Breslow) 
(Fig. 2). 
Cause of renal allograft failure 
Thirteen (42%) allografts failed during the follow-
up period. Causes of allograft failure were rejection 
(n = 8), primary nonfunction (n = 4) and renal vein 
thrombosis (n = 1), 
Allograft function 
As shown in Table 2, the delayed graft function 
rate was RR!~/;F in the older donor group (Group 
1) compared to 35% in the younger donor group 
(Group 2) (p<O.Ol). The mean serum creatinine 
(SCR) was significantly higher at L 3, and 12 
months in Group 1 than in Group 2 (Table 2). 
Regression analysis indicated that there was a sig-
Table 1. Older vs younger donors: demographics of recipients 
Recipient 
, 
Not of Patients 
Median Age 
Malel Female 
Diabetics 
PRA >20% 
Group 1 Group 2 
(Donors aged 60 yr) (Donors Aged 18-50 yr) 
31 
41 yr (24-71) 
2417 
4 (13%) 
7 \23%) 
31 
43 yr (28-72) 
21110 
6 (19%) 
11 (35%) 
Table 2. Older vs younger donors: Comparison of allograft function excluding 
donor organs with CIT> 48 h 
Group 1 Group 2 
(Donors aged (Donors aged 
>60 yr) 18-50 yr) p' l 
~ 
ATN 55% 35% <001 
Serum Cr (mg/dl) 
1 Month 4.2 3.0 0.03 
3 Montr. 3.4 2.0 < 0.D1 
12 Month 3.3 1.7 <0.D1 
• Mann-Whitney rank sums test. 
nificant relationship between the CIT and SCR in 
the recipients of older donor kidneys. This trend 
was not evident in patients who received kidneys 
from younger donors (Fig. 3). Ten recipients of 
older donor kidneys had SCR greater than 3.0 mg! 
dl at I yr. Nine (9(YYC)) of these are still functioning 
at a median follow-up of 17 months (range 13-41 
months). and 6 have lower SCR's at last follow-up 
compared to their SCR's at I yr. Recipients of 
older donor kidneys had similar 12-h trough HPLC 
CSA levels to those of younger donor kidneys 
(Table 3). There was no deliberate attempt to alter 
cyclosporine doses or levels in :e~ipients of older 
donor kidneys compared to reCIpIents of younger 
donor kidneys. 
Discussion 
In a SEOPF study of 6152 cadaveric kidneys recov-
ered bdween 1977 and 1982. 1264 (20u/o) were dis-
carded (3). Older donor age and death from cere-
brovascular accidents (CVA) were among the more 
frequent reasons cited for non-utilization of kid-
neys. Kidneys from females older than 30 yr and 
kidneys from CVA donors have poorer graft sur-
vival 'rates than kidneys recovered from young 
male trauma victims (2). Female and CVA donors 
each comprised 68"·(j of the older donors reported 
here. 
Kidney function declines with age. Renal mass 
may be reduced by up to 27% by the 8th decade 
(4) 'and is accompanied by a decline in glomerular 
Table 3 Cyclosporine levels-alder vs younger donors 
Time post-transplant 
1 week 
1 month 
3 months 
6 months 
Mean Cyclosporine levels (12 hour trough 
HPLC±SD.) 
Donor Age > 60 Donor Age < 60 
228±101 302±178 
329±140 342±160 
220:134 246±165 
214:171 173±59 
P 
0.28 
0.89 
0.65 
0.48 
Cad· 60 ~r T, 
filtration rate. In one studv. inulin clearance de-
creased from 122.8 to 65.3 ml'min lKT~ m: he-
tween the ages of 20 and 90 (5). a decline of 4()" II. 
Over the age of 30. G FR decreases by lUI m I 
minute/yr (6) but, owing to decreased muscle mass. 
this GFR reduction is not reflected in serum creati, 
nine (SCR), which retains the same value as in 
young adulthood. Calculation of creatinine clear-
ance by use of the Gault-Cockroft (7) formula 
might be more appropriate in the pretransplant 
assessment of older donor kidneys. Virtually all 
functions are altered; afferent and efferent arteriol-
ar resistance is increased, contributing to a decrease 
in renal blood flow and increased filtration frac-
tion. Renal cortical blood flow is particularly de-
creased. Other functions such as autoregulation. 
sodium retention. urinary concentrating ability and 
capacity to excrete an acid load are also reduced 
(4). Histologically, senescent glomeruli are found 
in greater numbers. Kaplan et al. (8) in an autopsy 
study of 122 patients older than 60 yr, found that 
up t~ 15% of the glomeruli were sclerotic. In our 
series. pretransp1ant biopsy was performed in 11 
EPSE~/oF renal allografts. In 7 kidneys sclerosis in-
volved 5% of glomeruli. and in 4 kidneys sclerosis 
involved R-1OE~·!EF of glomeruli. The biopsy findings 
did not have predictive value as far as allograft 
outcome was concerned. 
With decreased renal blood flow. lower GFR 
and impaired autoregulatory capacity older kid-
neys may be more sensitive to ischemia and toxic 
insults. Takemoto and Terasaki (9) reported that 
kidneys from donors older than 65 yr had a 23% 
poorer graft survival than kidneys from 16-yr-old 
donors Thev also showed that the lower survival 
was m~re n~ticeab1e after 1985. thus implicating 
cyc1osporine in this trend. All our patients received 
cyclosporine. Kidneys from older donors may also 
be more sensitive to the effects of cold ischemia. 
Our l-yr allograft survival was 38% for kidneys 
with CIT of 48 h or higher compared to 76"/0 for 
those with CIT less than 48 h (p < 0.04). Four (50(Yo) 
of the kidneys with a CIT greater than 48 h never 
functioned. if kidneys with a CIT greater than 48 
h are excluded from this analysis the 76% I-yr graft 
survival compares favorably with the graft survival 
in the recipients of the younger donor kidneys. The 
major graft loss was in the group of kidneys with 
prolonged cold ischemia. Fig. I illustrates. that such 
graft loss occurs early and that the surVival curve 
parallels that of the younger kidneys after the 1st 
month. 
Renal function in surviving grafts from the older 
donor has not been addressed in the literature. 
Even excluding donor kidneys with CIT greater 
than 48 h. the renal function is poorer than in 
kidneys from donors between 18-50 yr. The mean 
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SCR in recipients of the older kidneys was 4.2, 
3.4, and 3.3 mg/ dl at 1, 3, and 12 months post-
transplant. This was significantly inferior to the 
function in the younger donor group in whom 
SCR's were 3.0, 2.0, and 1.7 mg/dl (p=0.03, 
<0.01, and <0.01 Mann-Whitney Rank Sums). 
Eventual renal function was significantly corre-
lated with CIT in these older kidneys but this was 
not the case in the younger donor group. Ten of the 
17 recipients of older donor kidneys functioning at 
1 yr had SCR's greater than 3.0 mg/ dl. Only I of 
these kidneys has subsequently failed. Of the 9 still 
functioning (follow-up ranging from 13-41 
months), 6 have better renal function at most re-
cent follow-up compared to SCR at I yr. Therefore. 
while these kidneys function with a higher SCR 
than kidneys from younger donors this does not 
preclude long-tenn graft survival. 
In conclusion, kidneys from donors over 60 yr 
of age function with a higher SCR at L 3, and 12 
months than kidneys from younger donors. They 
are probably better used in older recipients who 
will make less metabolic demands on the kidney. 
Low PRA recipients should be selected as the re-
duced functional reserve of these kidneys may im-
pair recovery from injury. They appear to be more 
sensitive to cold ischemia and probably should not 
be used with a CIT greater than 48 h. Selective 
80 
use of these donors can provide dialysis-free life, 
increase the donor pool, and make available 
younger kidneys for patients expected to make 
greater physiological demands on their graft. 
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